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Slow induction of brain death leads 
to decreased renal function and increased 
hepatic apoptosis in rats
Rolando A. Rebolledo1,2*† , Dane Hoeksma1†, Christina M. V. Hottenrott3, Yves J. L. Bodar1, Petra J. Ottens1, 
Janneka Wiersema‑Buist1 and Henri G. D. Leuvenink1
Abstract 
Background: Donor brain death (BD) is an independent risk factor for graft survival in recipients. While in some 
patients BD results from a fast increase in intracranial pressure, usually associated with trauma, in others, intracranial 
pressure increases more slowly. The speed of intracranial pressure increase may be a possible risk factor for renal and 
hepatic graft dysfunction. This study aims to assess the effect of speed of BD induction on renal and hepatic injury 
markers.
Methods: BD induction was performed in 64 mechanically ventilated male Fisher rats by inflating a 4.0F Fogarty 
catheter in the epidural space. Rats were observed for 0.5, 1, 2 or 4 h following BD induction. Slow induction was 
achieved by inflating the balloon‑catheter at a speed of 0.015 ml/min until confirmation of BD. Fast induction was 
achieved by inflating the balloon at 0.45 ml/min for 1 min. Plasma, kidney and liver tissue were collected for analysis.
Results: Slow BD induction led to higher plasma creatinine at all time points compared to fast induction. Further‑
more, slow induction led to increased renal mRNA expression of IL‑6, and renal MDA values after 4 h of BD compared 
to fast induction. Hepatic mRNA expression of TNF‑α, Bax/Bcl‑2, and protein expression of caspase‑3 was significantly 
higher due to slow induction after 4 h of BD compared to fast induction. PMN infiltration was not different between 
fast and slow induction in both renal and hepatic tissue.
Conclusion: Slow induction of BD leads to poorer renal function compared to fast induction. Renal inflammatory 
and oxidative stress markers were increased. Liver function was not affected by speed of BD induction but hepatic 
inflammatory and apoptosis markers increased significantly due to slow induction compared to fast induction. These 
results provide initial proof that speed of BD induction influences detrimental renal and hepatic processes which 
could signify different donor management strategies for patients progressing to BD at different speeds.
Keywords: Brain death, Organ donation, Kidney transplantation, Liver transplantation
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Background
The shortage of qualitative donor organs remains a lim-
iting factor in organ transplantation. Therefore, resort-
ing to sub-optimal donor types to meet the increasing 
demand of organs is inevitable. Today, brain-dead donors 
form the largest donor pool worldwide for kidney and 
liver transplantation [1, 2]. Unfortunately, transplant-
ing kidneys from brain dead donors leads to higher inci-
dences of rejection and delayed graft function compared 
to living donors [3]. A cerebrovascular cause of BD is 
related to renal and liver graft failure indicating that the 
nature of brain insults affects graft function as well [4, 5].
Brain death (BD) is a complex pathological condi-
tion, characterized by hemodynamic imbalance, hormo-
nal impairment, and a systemic inflammatory response. 
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brainstem herniation, the resulting catecholamine storm, 
and neurogenic shock due to ischemia of the spinal cord. 
Systemic inflammation is characterised by increased 
levels of circulating cytokines including interleukin-6 
(IL-6), interleukin-10 (IL-10), tumor necrosis factor-
alpha (TNF-α), transforming growth factor-beta (TGF-
β) and, monocyte chemotactic protein 1 (MCP-1) [6–8]. 
This systemic inflammatory environment promotes the 
migration of inflammatory cells into organs triggering 
a local inflammatory and (pro-)apoptotic response [9, 
10]. Furthermore, BD affects pituitary function caus-
ing a decrease in plasma levels of cortisol, thyroid hor-
mones (T3/T4), insulin, and antidiuretic hormone (ADH) 
[11–13].
Brain death-related processes such as the catechola-
mine storm are affected by the speed at which intracra-
nial pressure (ICP) increases. A faster increase in ICP 
leads to higher levels of circulating catecholamines which 
is detrimental for cardiac and pulmonary graft function 
[14]. Indeed, traumatic brain injury, the most common 
cause of BD preceded by a rapid increase in ICP, is a 
risk factor for mortality in heart recipients [15]. In con-
trast, a cerebrovascular cause of death, usually preceded 
by a slower increase in ICP, is a risk factor for renal and 
hepatic graft dysfunction. However, this phenomenon 
is not believed to be associated with a slower increase 
in ICP. Rather, donor characteristics such as obesity, 
older age, and the presence of cardiovascular disease are 
regarded as the underlying cause [5, 16, 17].
We aimed to assess whether the speed of BD induction 




Sixty-four male Fisher F344 rats (270–300  g) were sub-
jected to either fast or slow BD induction with a BD 
duration of 0.5, 1, 2 or 4 h. All animals received care in 
compliance with the guidelines of the local animal ethics 
committee according to the Experiments on Animals Act 
(1996) issued by the Ministry of Public Health, Welfare 
and Sports of the Netherlands. Animals were anaesthe-
tized using 2–5 % isoflurane with 100 % oxygen. Two mil-
lilitre saline was administered s.c. to prevent dehydration. 
Animals were intubated via a tracheostomy and ventilated 
(tidal volume: 6.5 ml/kg of body weight, PEEP of 3 cm of 
H2O at an initial respiratory rate of 120 and was adjusted 
to maintain the ETCO2 in normocapnia range) through-
out the experiment. Cannulas were inserted in the femo-
ral artery and vein for continuous mean arterial pressure 
(MAP) monitoring and volume replacement. Through a 
frontolateral hole drilled in the skull, a no. 4 Fogarty cath-
eter (Edwards Lifesciences Co, Irvine, CA) was placed in 
the epidural space and inflated with saline using a syringe 
pump (Terufusion, Termo Co., Tokyo, Japan). Fast and 
slow induction of BD were induced by inflating the cath-
eter at a speed of 0.45 or 0.015 ml/min, respectively. For 
slow speed induction, inflation of the balloon was termi-
nated when the MAP increased above 80 mmHg due to 
the catecholamine storm. For fast induction, the catheter 
was inflated over a period of 1 min. BD was confirmed by 
the absence of corneal reflexes half an hour after induc-
tion after which anaesthesia was discontinued. MAP was 
maintained above 80  mmHg. If necessary, colloid infu-
sion with 10  % polyhydroxyethyl starch (HAES) (Frese-
nius Kabi AG, Bad Homburg, Germany) was given in a 
bolus (limited to a maximum of 1 ml/h) to maintain the 
MAP above 80 mmHg. Unresponsiveness to HAES indi-
cated the start of an intravenous noradrenaline (NA) drip 
(1 mg/ml). A homeothermic blanket control system was 
used throughout the experiment, maintaining the body 
temperature between 37 and 38  °C. At the end of the 
experimental period, blood and urine were collected, and 
the animals were systemically flushed with cold saline. 
After the flush, organs were harvested and tissue samples 
were snap frozen in liquid nitrogen and stored at −80 °C 
or fixated in 4 % paraformaldehyde. Plasma samples and 
urine were also snap-frozen and stored. One animal was 
discarded in the slow induction 2  h group, two animals 
in the fast induction group 2 h and one in the fast induc-
tion 4 h group due to unknown amounts of noradrena-
line administration. One animal was discarded in the fast 
induction 4 h group due to an apnea test conducted dur-
ing the BD period.
Animals were randomly assigned to one of 8 experi-
mental groups (n = 8):
Fast BD induction 0.5 h
Fast BD induction 1 h
Fast BD induction 2 h
Fast BD induction 4 h
Slow BD induction 0.5 h
Slow BD induction 1 h
Slow BD induction 2 h
Slow BD induction 4 h
Biochemical determinations
Plasma levels of alanine transaminase (ALT), aspartate 
transaminase (AST) and creatinine were determined at 
the clinical chemistry lab of University Medical Centre 
Groningen according to standard procedures.
Plasma IL‑6 measurement
Plasma IL-6 was determined by a rat enzyme-linked 
immunosorbent assay (IL-6 ELISA) kit (R&D Systems 
Europe Ltd. Abingdon, Oxon OX14 3NB, UK), according 
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to the manufacturer’s instructions. All samples were ana-
lyzed in duplicate and read at 450 nm.
RNA isolation and cDNA synthesis
Total RNA was isolated from whole liver and kidney sec-
tions using TRIzol (Life Technologies, Gaithersburg, 
MD). Samples were verified for absence of genomic DNA 
contamination by performing RT-PCR reactions in which 
the addition of reverse transcriptase was omitted, using 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
primers. For cDNA synthesis, 1  μl T11VN Oligo-dT 
(0.5 μg/μl) and 1 μg mRNA were incubated for 10 min at 
70  °C and cooled directly after that. cDNA was synthe-
sized by adding a mixture containing 0.5 μl RnaseOUT® 
Ribonuclease inhibitor (Invitrogen, Carlsbad, USA), 
0.5 μl RNase water (Promega), 4 μl 5× first strand buffer 
(Invitrogen), 2  μl DTT (Invitrogen), 1  μl dNTP’s and 
1  μl  M-MLV reverse transcriptase (Invitrogen, 200  U). 
The mixture was held at 37 °C for 50 min. Next, reverse 
transcriptase was inactivated by incubating the mixture 
for 15 min at 70 °C. Samples were stored at −20 °C.
Real‑time PCR
Fragments of several genes were amplified with the 
primer sets outlined in Table  1. Pooled cDNA obtained 
from brain-dead rats was used as an internal reference. 
Gene expression was normalized with the mean of 
β-actin mRNA content. Real-Time PCR was carried out 
in reaction volumes of 15  μl containing 10  μl of SYBR 
Green mastermix (Applied biosystems, Foster City, USA), 
0.4  μl of each primer (50  μM), 4.2  μl of nuclease free 
water and 10 ng of cDNA. All samples were analyzed in 
triplicate. Thermal cycling was performed on the Taqman 
Applied Biosystems 7900HT Real Time PCR System with 
a hot start for 2 min at 50 °C followed by 10 min 95 °C. 
Second stage was started with 15  s at 95  °C (denatura-
tion step) and 60  s at 60  °C (annealing step and DNA 
synthesis). The latter stage was repeated 40 times. Stage 
3 was included to detect formation of primer dimers 
(melting curve) and begins with 15 s at 95 °C followed by 
60  s at 60  °C and 15  s at 95  °C. Primers were designed 
with Primer Express software (Applied Biosystems) and 
primer efficiencies were tested by a standard curve for 
the primer pair resulting from the amplification of seri-
ally diluted cDNA samples (10, 5, 2.5, 1.25 and 0.625 ng) 
obtained from brain-dead rats. PCR efficiency was 
1.8 < ε < 2.0. Real-time PCR products were checked for 
product specificity on a 1.5  % agarose gel. Results were 
expressed as 2−△△CT (CT: threshold cycle).
HIS 48 immunological staining
Five-micrometer renal and hepatic cryostat sections were 
fixed in acetone and stained according to standard pro-
tocol. In brief, mouse monoclonal anti-rat granulocyte 
antibody (HIS 48; IQ products, Groningen) was dis-
solved in PBS (pH 7.4) supplemented with 1  % bovine 
serum albumin (BSA). Peroxidase-labeled second step 
antibody (rabbit anti-mouse) was diluted in 1  % BSA/
PBS containing 5 % normal rat serum. Peroxidase activity 
was visualized using aminoethylcarbazole. Sections were 
counterstained with Mayers Hemotoxylin. Control sec-
tions were incubated with omission of the primary anti-
body. For each tissue section, positive cells per field were 
counted by a blinded researcher in ten microscopic fields 
of the tissue at 20× and 10× magnification for the kidney 
and liver respectively. Results were presented as number 
of positive cells per field.
Tissue MDA
Kidney and liver tissue was homogenized with a pestle 
and mortar in PBS containing 5 mM butylated hydroxy-
toluene. Malondialdehyde (MDA) was measured fluo-
rescently after binding to thiobarbituric acid. Hundred 
microlitre of tissue homogenate was mixed with 2  % 
SDS followed by 400 μl 0.1 N HCL, 50 μl 10 % phospho-
tungstic acid and 200  μl 0.7  % TBA. The mixture was 
incubated for 30 min at 97 °C. Eight hundred microlitre 
1-butanol was added to the samples and centrifuged at 
960g. Two hundred microlitre of the 1-butanol superna-
tant was fluorescently measured at 480 nm excitation and 
590  nm emission wavelengths. Samples were corrected 
for total amount of protein.
Cleaved caspase‑3 staining
To detect caspase-3 positive cells in liver and kidney, 
immunohistochemistry was performed on 3 μm sections 
of paraffin embedded liver samples. Sections were depar-
affined in a sequence of xylene, alcohol and water. As an 
antigen retrieval method we used for caspase-3 samples: 
EDTA (1 mM, pH 8.0) buffer. Next, sections were stained 
with Caspase-3 primary Antibody (Cell Signaling cat. nr. 
9661, 100× diluted in 1  % BSA/PBS) using an indirect 
immunoperoxidase technique. Endogenous peroxidase 
Table 1 Primer sequences used for real-time PCR
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was blocked using H2O2 0.3  % in phosphate-buffered 
saline for 30  min. After thorough washing, sections 
were incubated with horseradish peroxidase-conjugated 
goat anti-rabbit IgG as a secondary antibody for 30 min 
(Dako, Glostrup, Denmark. cat. nr. P0448), followed by 
rabbit anti-goat IgG as a tertiary antibody for 30  min 
(Dako, Glostrup, Denmark. cat. nr. P0449). The reac-
tion was developed using DAB as chromogen and H2O2 
as substrate. Sections were counterstained using Mayer 
hematoxylin solution (Merck, Darmstadt, Germany). 
Negative antibody controls were performed. Localization 
of immunohistochemical staining was assessed by light 
microscopy. For each tissue section, positive cells per 
field were counted by a blinded researcher in ten micro-
scopic fields of the tissue at 10× magnification. Results 
were presented as number of positive cells per field.
Statistical analyses
Statistical analysis was performed between both experi-
mental groups using a nonparametric test (Mann–
Whitney) for every time point. All statistical tests were 
2-tailed and p < 0.05 was regarded as significant. Results 
are presented as mean ± SD (standard deviation).
Results
As an internal control we compared the catheter volume 
after brain death induction and blood pressure pattern 
during the induction phase. The final catheter volume 
was similar between the slow and fast induction model 
(0.41 ± 0.03 ml vs 0.41 ± 0.02). During BD induction, the 
MAP showed different characteristic patterns due to fast 
and slow speed induction (Fig. 1). Slow speed BD induc-
tion was characterized by a period of decreased blood 
pressure which typically started 10  min before the end 
of the induction and in which the minimum pressure 
registered was 51.17  ±  10.76  mmHg. In contrast, fast 
speed induction was characterized by a sudden and short 
increase in MAP which was typically observed at the end 
of the balloon inflation period and in which the maxi-
mum pressure registered was 167.39 ± 37.85 mmHg.
The amount of HAES needed for a stable MAP was 
similar after fast and slow speed induction. The amount 
of administered NA was significantly higher in the fast 
induction group compared to slow induction after 0.5 
and 1  h of BD (Table  2). We estimated the chance of 
noradrenaline and HAES utilization using hazard curves. 
Slow induction led to a 17.05 % probability of NA use in 
the first hour of BD, while fast induction led to a 54.84 % 
probability. Additionally, we compared both curves using 
the Mantel–Cox test. The curves for NA use were signifi-
cantly different (p = 0.0004). HAES was used mainly in 
the first minutes after BD induction. Slow induction led 
to a 48.39 % probability of HAES use in the first 10 min 
of BD while fast induction led to a 84.38  % probability. 
Curve comparison was found to be significantly different 
using the Mantel–Cox test (p = 0.0091, Fig. 2).
ALT and AST plasma levels were measured as liver cell 
injury markers. No differences were found in ALT levels 
between fast and slow speed induction. The AST plasma 
levels were increased due to fast induction compared to 
slow induction groups after 0.5 and 2 h of BD (p = 0.0225 
and p = 0.0088, Fig. 3).
Plasma creatinine levels were measured in order to 
estimate kidney function. Creatinine was significantly 
higher after slow induction compared to fast induction at 
every time point. Plasma urea levels were increased due 
to slow induction compared to fast induction after 4 h of 
BD (p = 0.0308, Fig. 3).
Plasma IL-6 levels were measured as a marker for sys-
temic inflammation. IL-6 plasma levels were significantly 
Fig. 1 Course of MAP during BD induction and during 4‑h BD in fast‑ 
(n = 32) and slow‑ (n = 35) inducted rats. T = 0 represents the start 
of the BD period
Table 2 Total noradrenaline (1  mg/ml) and  HAES 10  % 
infusion requirements
Asterisk indicates p < 0.05





0.5 0.35 ± 0.42 0.10 ± 0.24 0.0188*
1 0.55 ± 0.76 0.05 ± 0.14 0.0238*
2 1.1 ± 1.6 0.13 ± 0.25 0.1515
4 0.33 ± 0.58 0.23 ± 0.42 0.8564
HAES 10 % (ml) 0.5 0.44 ± 0.18 0.31 ± 0.26 0.5692
1 0.56 ± 0.18 0.50 ± 0.0 0.9999
2 0.50 ± 0.0 0.38 ± 0.35 0.2000
4 0.56 ± 0.50 0.56 ± 0.42 0.9999
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Fig. 2 Hazard curves for Noradrenaline and HAES utilization in in fast‑ (n = 32) and slow‑ (n = 35) inducted rats. Asterisk indicates p < 0.05
Fig. 3 Plasma levels of injury markers and function markers in fast inducted rats 0.5 (n = 8), 1 (n = 8), 2 (n = 6), and 4 h (n = 6) and slow inducted 
rats 0.5 (n = 8), 1 (n = 8), 2 (n = 7), and 4 h (n = 8) after BD. Asterisk indicates p < 0.05
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increased due to slow induction compared to fast induction 
after 0.5 and 1 h of BD (p = 0.0014 and p = 0.0002, Fig. 4).
We assessed tissue inflammation by measuring the 
relative expression of pro-inflammatory genes in the kid-
ney and liver. Relative TNF-α gene expression in the kid-
ney showed no differences between fast and slow speed 
induction. In contrast, the relative IL-6 gene expres-
sion increased significantly due to slow induction com-
pared to fast induction after 0.5 and 4 h (p = 0.0348 and 
p  =  0.0270, Fig.  5a). Hepatic TNF-α gene expression 
increased significantly due to slow induction compared 
to fast induction after 4 h of BD (p = 0.0293). No differ-
ence was found in the relative gene expression of IL-6 
between fast and slow induction (Fig. 5b). PMN infiltra-
tion in renal and hepatic tissue was assessed by His-48 
staining. There was no difference in His-48 positive stain-
ing in the renal cortex and hepatic tissue between fast 
and slow induction (Fig. 6).
In order to study apoptotic pathways in renal and 
hepatic tissue, we measured the ratio between the rela-
tive Bax and Bcl-2 expression. No difference was found 
in the expression of this ratio in renal tissue between fast 
and slow induction. In contrast, the hepatic gene expres-
sion of the Bax/Bcl-2 ratio was significantly higher due 
to slow induction compared to fast induction after 4 h of 
BD (p = 0.0293, Fig. 7). Additionally, hepatic cleaved cas-
pase-3 protein expression was significantly increased due 
to slow induction compared to fast induction after 4 h of 
BD (p = 0.001, Fig. 8).
Oxidative stress was assessed by measuring lipid per-
oxidation. MDA levels were significantly higher in renal 
tissue due to slow induction compared to fast induction 
after 4 h of BD (p = 0.01). Hepatic MDA levels were com-
parable between fast and slow induction groups after 4 h 
of BD (p = 0.48, Fig. 9).
Discussion
The speed at which brain insults progress to BD var-
ies greatly in ICU patients. Even donors with the same 
nature of brain insults progress to BD at different speeds. 
After infarction of the middle cerebral artery, BD can 
typically manifest itself anywhere between 24  h and a 
week [18]. In a prospective study of patients with suba-
rachnoid hemorrhage who progressed to BD, 26 % were 
still not declared BD after 1 week [19]. This large range in 
time intervals is the result of the complex pathophysiol-
ogy of the processes leading to BD and reflective of the 
speed at which ICP increases [20]. As of yet, the speed at 
which ICP increases, has not been investigated as a pos-
sible determinant of renal and hepatic graft survival.
Here we report for the first time that the speed of BD 
induction affects functional, immunologic, apoptotic, 
and oxidative stress markers in the kidney and liver. In 
our experimental setting, we found that a slower speed of 
BD induction, elicits more detrimental renal and hepatic 
effects compared to a faster speed of BD induction. The 
effect of slower speed of BD induction is especially appar-
ent in the kidney as renal function is diminished which 
was measured by serum creatinine values.
We showed that faster BD induction leads to more 
hemodynamic instability in the first hour after BD induc-
tion and therefore higher amounts of noradrenaline and 
HAES were required during this time period to maintain 
MAP within the physiological range. This is probably 
related to the higher peak of plasma catecholamine levels 
caused by fast BD induction as was shown by Shivalkar 
et  al. [14]. Higher levels of catecholamines lead to 
increased myocardial load and injury. Myocardial injury 
causes a subsequent drop in blood pressure and increases 
the need of hemodynamic support [13]. The negative 
effect of fast speed induction on hemodynamic stability 
appears to fade over time as the administered amount 
of HAES and NA did not differ between fast and slow 
induction at 2 and 4 h of BD.
In our experiment, the effects of speed of BD induction 
on the kidney and liver become especially evident at later 
time-points of the BD period. Differences between both 
models with regard to the kidney are clearer since creati-
nine levels increase over time in both models but are sig-
nificantly higher due to slow induction at all time points. 
The hypotensive phase observed during slow speed 
induction could explain the decreased renal function 
(prerenal acute kidney injury) at early BD time points 
which forms a “first hit” in slow-inducted rats. However, 
Fig. 4 IL‑6 plasma levels in in fast inducted rats 0.5 (n = 8), 1 (n = 8), 
2 (n = 6), and 4 h (n = 6) and slow inducted rats 0.5 (n = 8), 1 (n = 8), 
2 (n = 7), and 4 h (n = 8) after BD. Asterisk indicates p < 0.05
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renal function shows no improvement over the course of 
the BD period even when MAP is maintained within the 
physiological range. Moreover, progressive diminished 
renal function was also observed after fast induction in 
which a hypotensive phase did not occur which indicates 
that local changes in the renal microcirculation are more 
likely to have caused the decreased renal function during 
the later stages of BD. We think that changes observed 
during the later stages of BD form a “second hit” in slow-
inducted rats while this comprises the first (and single) 
hit in fast-inducted rats. Changes observed in the later 
stages of BD can be the result of one of the sole or com-
bined effects of hemodynamic instability, inflammation, 
and hormonal impairment [7, 21, 22]. Furthermore, It 
is known that colloids like HAES can cause decreased 
renal function [23]. However, this could not explain the 
difference observed between groups, considering there 
was no difference in the administered amounts of HAES 
between fast- and slow-inducted rats. We therefore think 
that future studies should focus on the effect of speed 
of BD induction on graft function after transplantation. 
Possibly, strategies to ameliorate kidney function, such 
as machine perfusion, could be most advantageous in 
donors in which progression to BD occurs over a longer 
time period.
Fig. 5 Relative expression of inflammatory genes in renal and hepatic tissue in fast inducted rats 0.5 (n = 8), 1 (n = 8), 2 (n = 6), and 4 h (n = 6) and 
slow inducted rats 0.5 (n = 8), 1 (n = 8), 2 (n = 7), and 4 h (n = 8) after BD. The fold induction represents the relative expressions of these genes as 
compared to the expression level of the housekeeping GAPDH gene. Asterisk indicates p < 0.05
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Plasma ALT and AST levels are known to increase 
in brain-dead rats [6, 24]. In our experiment ALT lev-
els, reflective of liver cell injury, showed no differences 
between both induction methods. However, AST lev-
els were higher due to fast induction compared to slow 
induction after 0.5 and 2 h BD. We believe this not to be 
a reflection of liver damage due to no concurrent rise 
in ALT. Moreover, since AST is found in many tissues 
including the heart and lung, the early timepoints after 
which AST is increased, imply a causative role of the cat-
echolamine storm and could be a reflection of lung and/
or heart damage since these organs are affected by high 
levels of circulating catecholamines.
IL-6 is the cytokine most often implicated in brain 
death [25–28]. Plasma IL-6 levels increased significantly 
after slow induction compared to fast induction after 0.5 
and 1 h of BD. This difference disappears over the course 
of the BD period which could be explained by the above 
Fig. 6 Polymorphonuclear (PMN) influx in renal and hepatic tissue after 4 h of BD. Kidneys after a fast induction (n = 6) and b slow induction 
(n = 6) ×20 magnification factor. Livers after c fast induction (n = 6) and d slow induction (n = 6) ×10 magnification factor
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mentioned “first” and “second hit” in fast- and slow-
inducted rats respectively. Therefore, systemic inflamma-
tory markers like IL-6 might not be a good reflection of 
local inflammatory responses as these can be masked by 
the widespread events occurring in the brain dead donor.
The speed of BD induction leads to differences in 
immunologic and apoptotic responses in the kidney 
and liver. Renal IL-6 mRNA expression was signifi-
cantly higher at 0.5 and 4  h BD due to slow BD induc-
tion which could be explained by the second hit theory as 
explained above. However, no differences in PMN influx 
were observed between both models which could be due 
to the fact that 4  h of BD was not sufficient to reveal a 
difference. Hepatic IL-6 levels did not differ between 
models and neither was there a difference in PMN influx. 
However, hepatic mRNA expression of TNF-α was sig-
nificantly increased due to slow induction compared to 
fast induction after 4  h of BD. A concurrent significant 
increase was observed in the expression of caspase-3 due 
to slow induction. TNF-α is a known inducer of extrinsic 
apoptosis and therefore signalling through death receptor 
mediated pathways is plausible in our model [29]. Since 
TNF-α has a major implication in hepatic ischemia–
reperfusion injury, hepatic TNF-α levels in human 
donors that progress to BD at different speeds should 
be assessed. [30–32]. Hepatic mRNA expression of the 
BAX/BcL-2 ratio was also significantly increased due to 
slow induction compared to fast induction which also 
suggests a possible role of intrinsic apoptosis through 
the permeabilization of mitochondria. The causal rela-
tionship of these processes and how they are initiated 
remains unclear and therefore, future investigations 
should focus on them in more depth. However, a possible 
cause could be the deposition of complement which has 
shown to occur in livers of brain-dead rats and which is 
a known inducer of apoptosis [24]. Renal mRNA expres-
sion of the BAX/BcL-2 ratio was not different between 
fast and slow BD induction. Moreover, there was no renal 
expression of caspase-3 after both fast and slow induc-
tion. This could indicate that the renal insults caused by 
BD are not severe enough to initiate programmed cell 
death or that other forms of cell death are initiated which 
we did not study.
The formation of oxidative stress in brain dead kid-
neys has been well documented [25, 33]. Lipid peroxi-
dation, an oxidative stress marker, in brain dead donors 
is an independent risk factor for renal graft dysfunction 
in transplant recipients [34]. We report here that slower 
BD induction leads to more renal lipid peroxidation 
compared to fast induction. We believe that possible 
changes in the renal microcirculation could be related 
to the observed differences in lipid peroxidation. In the 
context of acute kidney injury, oxidative processes medi-
ate peritubular microcirculatory changes which lead to 
diminished renal perfusion and function [35, 36]. How-
ever, causal roles between microcirculatory changes and 
lipid peroxidation cannot be inferred from this study. 
No difference was observed in hepatic lipid peroxidation 
Fig. 7 Ratio of the relative BAX/Bcl‑2 expressions in the kidney and liver in fast inducted rats 0.5 (n = 8), 1 (n = 8), 2 (n = 6), and 4 h (n = 6) and 
slow inducted rats 0.5 (n = 8), 1 (n = 8), 2 (n = 7), and 4 h (n = 8) after BD. The fold induction represents the relative expressions of these genes as 
compared to the expression level of the household GAPDH gene. Asterisk indicates p < 0.05
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between fast and slow BD induction which implies that 
oxidative stress does not influence other hepatic effects 
we observed.
Conclusion
The presented data provide an initial broad overview 
of changes elicited by the speed of BD induction. We 
found that a slower speed of BD induction leads to more 
detrimental effects in the kidney and liver. This could 
indicate that speed of BD induction should be taken 
into account when decisions about organ allocation are 
made. The effects of speed of BD induction are more 
pronounced in the kidney as renal function is dimin-
ished more due to a slower speed. Nevertheless, hepatic 
inflammatory and apoptotic markers are increased 
more due to slow induction. We believe that increased 
Fig. 8 Cleaved‑caspase 3 expression in renal and hepatic tissue after 4 h of BD. Kidneys after a fast induction (n = 6) and b slow induction (n = 8) 
×10 magnification factor. Livers after c fast induction (n = 6) and d slow induction (n = 6) ×10 magnification factor. Asterisk indicates p < 0.01
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knowledge about the processes leading up to BD can be 
of valuable use for brain-dead donor management and 
thereby improve transplantation outcomes.
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